Schweiger Dermatology Group Leaving Midtown for Much Larger Digs in LIC
By Liam La Guerre July 21, 2017 6:47 pm
reprints
Schweiger Dermatology Group has signed a 21,463-square-foot sublease to relocate its headquarters to 27-01 Queens Plaza North in the Long Island City section of Queens, Commercial Observer has learned.
Schweiger, which provides medical, cosmetic and surgical dermatology services, will occupy the entire 10th floor of the 13-story Brause Realty-owned building between 27th and 28th Streets for six years, according to information provided by Newmark Knight Frank.
In September, the company will relocate from an 8,000-square-foot office at 156 West 56th Street between Avenue of the Americas and Seventh Avenue in Midtown, taking over the 10th floor from MetLife. The insurance giant controls 200,000 square feet at the 710,000-square-foot LIC building.
Newmark Knight Frank’s Ryan Gessin and Ross Perlman represented Schweiger, while a Cushman & Wakefield (CWK) team of Ethan Silverstein, Mitchell Arkin and Kelli Berke handled the deal for MetLife, the sublandlord.
“We were able to successfully structure a transaction, allowing Schweiger to more than double in space while maintaining similar occupancy costs,” Gessin said in prepared remarks.
A spokesman for the brokerage declined to disclose the asking rent in the transaction.
Schweiger, which provides services to more than 250,000 patients annually, has about 26 locations scattered around New York City, Long Island, Westchester County, Rockland County and New Jersey, according to its website.
“Our new corporate headquarters is strategically located to optimally serve our 26 offices, with the majority of our locations being throughout Manhattan and Long Island,” Schweiger Chief Executive Officer Dr. Eric Schweiger said in a statement provided to CO. “We will be able to efficiently support our providers and patients as our business continues to grow. We look forward to getting to know our new home at Queens Plaza.”
The C&W brokers did not immediately return a request for comment via a spokesman.
